Characterization and antivirus activities of a novel bovine IFN-omega24

Molecular Immunology

Volumn 66, Issue 2, 2015, Pages 357-363

  Luo, Xiuxin ^a   Guo, Yongli ^a   Bao, Jun ^a,b   Liu, Ying ^a   An, Dong ^a   Ma, Bo ^a   Gao, Mingchun ^a   Wang, Junwei ^a,b  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b Synergetic Innovation Center of Food Safety and Nutrition   (China)

Author keywords

Antiproliferation activity; Antiviral activity; Bovine; IFN 24; Physicochemical characteristics

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BOVINE INTERFERON OMEGA 24; INTERFERON; TRYPSIN; UNCLASSIFIED DRUG; DNA; INTERFERON OMEGA 1; ISOPROTEIN; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BOVINE INTERFERON OMEGA 24 GENE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG STABILITY; ESCHERICHIA COLI; GENE; GENE EXPRESSION SYSTEM; IN VITRO STUDY; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPERATURE MEASUREMENT; VESICULOVIRUS; AMINO ACID SEQUENCE; ANIMAL; BOVINE; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; CRICETULUS; DRUG EFFECTS; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYLOGENY; PIG; PROTEIN STABILITY;

BOVINAE; ESCHERICHIA COLI;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; BASE SEQUENCE; CATTLE; CELL LINE; CELL PROLIFERATION; CRICETULUS; DNA; ESCHERICHIA COLI; GENE EXPRESSION; INTERFERON TYPE I; LIVER; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN ISOFORMS; PROTEIN STABILITY; RECOMBINANT PROTEINS; SWINE; TRYPSIN; VESICULOVIRUS;

EID: 84928895920     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2015.04.009     Document Type: Article

References (38)

1. Adolf G.R., Fruhbeis B., Hauptmann R., Kalsner I., Maurer-Fogy I., Ostermann E., Patzelt E., Schwendenwein R., Sommergruber W., Zophel A. Human interferon omega 1: isolation of the gene, expression in Chinese hamster ovary cells and characterization of the recombinant protein. Biochim. Biophys. Acta 1991, 1089:167-174.
2. Altmann S.M., Mellon M.T., Distel D.L., Kim C.H. Molecular and functional analysis of an interferon gene from the zebrafish, Danio rerio. J. Virol. 2003, 77:1992-2002.
3. Bonjardim C.A. Interferons (IFNs) are key cytokines in both innate and adaptive antiviral immune responses - and viruses counteract IFN action. Microbes Infect. 2005, 7:569-578.
4. Boue O., Garcia J.L., Villar M., Alazo K., Perez A., Ramos E., Morales C., Morera O.L., Redondo M., Montero C., Rodriguez M. Antiviral and antiluteolytic activity of recombinant bovine IFN-omega1 obtained from Pichia pastoris. J. Interferon Cytokine Res. 2000, 20:677-683.
5. Buckwold V.E., Wei J., Huang Z., Huang C., Nalca A., Wells J., Russell J., Collins B., Ptak R., Lang W., Scribner C., Blanchett D., Alessi T., Langecker P. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses. Antivir. Res. 2007, 73:118-125.
6. Capon D.J., Shepard H.M., Goeddel D.V. Two distinct families of human and bovine interferon-alpha genes are coordinately expressed and encode functional polypeptides. Mol. Cell. Biol. 1985, 5:768-779.
7. Chaplin P.J., Entrican G., Gelder K.I., Collins R.A. Cloning and biologic activities of a bovine interferon-alpha isolated from the epithelium of a rotavirus-infected calf. J. Interferon Cytokine Res. 1996, 16:25-30.
8. Charlier M., L'Haridon R., Boisnard M., Martal J., Gaye P. Cloning and structural analysis of four genes encoding interferon-omega in rabbit. J. Interferon Res. 1993, 13:313-322.
9. Cheng G., Chen W., Li Z., Yan W., Zhao X., Xie J., Liu M., Zhang H., Zhong Y., Zheng Z. Characterization of the porcine alpha interferon multigene family. Gene 2006, 382:28-38.
10. Guo Y., Gao M., Bao J., Luo X., Liu Y., An D., Zhang H., Ma B., Wang J. Molecular cloning and characterization of a novel bovine IFN-epsilon. Gene 2015, 558:25-30.
11. Himmler A., Hauptmann R., Adolf G.R., Swetly P. Molecular cloning and expression in Escherichia coli of equine type I interferons. DNA 1986, 5:345-356.
12. Himmler A., Hauptmann R., Adolf G.R., Swetly P. Structure and expression in Escherichia coli of canine interferon-alpha genes. J. Interferon Res. 1987, 7:173-183.
13. Huang L., Cao R.B., Wang N., Liu K., Wei J.C., Isahg H., Song L.J., Zuo W.Y., Zhou B., Wang W.W., Mao X., Chen P.Y. The design and recombinant protein expression of a consensus porcine interferon: CoPoIFN-alpha. Cytokine 2012, 57:37-45.
14. Isaacs A., Lindenmann J. Virus interference. I. The interferon. By A. Isaacs and J. Lindenmann, 1957. J. Interferon Res. 1987, 7:429-438.
15. Isaacs A., Lindenmann J., Valentine R.C. Virus interference. II. Some properties of interferon. Proc. R. Soc. Lond. B: Biol. Sci. 1957, 147:268-273.
16. Ishiwata K., Minagawa T., Kajimoto T. Clinical effects of the recombinant feline interferon-omega on experimental parvovirus infection in beagle dogs. J. Vet. Med. Sci. 1998, 60:911-917.
17. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., Langer J.A., Sheikh F., Dickensheets H., Donnelly R.P. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 2003, 4:69-77.
18. Martin V., Najbar W., Gueguen S., Grousson D., Eun H.M., Lebreux B., Aubert A. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial. Vet. Microbiol. 2002, 89:115-127.
19. Ozes O.N., Reiter Z., Klein S., Blatt L.M., Taylor M.W. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities. J. Interferon Res. 1992, 12:55-59.
20. Pitha P.M., Kunzi M.S. Type I interferon: the ever unfolding story. Curr. Top. Microbiol. Immunol. 2007, 316:41-70.
21. Radhakrishnan R., Walter L.J., Hruza A., Reichert P., Trotta P.P., Nagabhushan T.L., Walter M.R. Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography. Structure 1996, 4:1453-1463.
22. Roberts R.M., Liu L., Alexenko A. New and atypical families of type I interferons in mammals: comparative functions, structures, and evolutionary relationships. Prog. Nucleic Acid Res. Mol. Biol. 1997, 56:287-325.
23. Rodriguez M., Martinez V., Alazo K., Suarez M., Redondo M., Montero C., Besada V., de la Fuente J. The bovine IFN-omega 1 is biologically active and secreted at high levels in the yeast Pichia pastoris. J. Biotechnol. 1998, 60:3-14.
24. Rubinstein S., Familletti P.C., Pestka S. Convenient assay for interferons. J. Virol. 1981, 37:755-758.
25. Ryan A.M., Womack J.E. Type I interferon genes in cattle: restriction fragment length polymorphisms, gene numbers and physical organization on bovine chromosome 8. Anim. Genet. 1993, 24:9-16.
26. Sambrook J., Sambrook J., Green M.R. Molecular Cloning: A Laboratory Manual 2012, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
27. Sandoval R., Xue J., Pilkinton M., Salvi D., Kiyokawa H., Colamonici O.R. Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines. J. Biol. Chem. 2004, 279:32275-32280.
28. Schultz U., Kock J., Schlicht H.J., Staeheli P. Recombinant duck interferon: a new reagent for studying the mode of interferon action against hepatitis B virus. Virology 1995, 212:641-649.
29. Sheppard P., Kindsvogel W., Xu W., Henderson K., Schlutsmeyer S., Whitmore T.E., Kuestner R., Garrigues U., Birks C., Roraback J., Ostrander C., Dong D., Shin J., Presnell S., Fox B., Haldeman B., Cooper E., Taft D., Gilbert T., Grant F.J., Tackett M., Krivan W., McKnight G., Clegg C., Foster D., Klucher K.M. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 2003, 4:63-68.
30. Tian L., Zhao P., Ma B., Guo G., Sun Y., Xing M. Cloning, expression and antiviral bioactivity of red-crowned crane interferon-alpha. Gene 2014, 544:49-55.
31. Tsang S.L., Leung P.C., Leung K.K., Yau W.L., Hardy M.P., Mak N.K., Leung K.N., Fung M.C. Characterization of murine interferon-alpha 12 (MuIFN-alpha12): biological activities and gene expression. Cytokine 2007, 37:138-149.
32. van Pesch V., Michiels T. Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. J. Biol. Chem. 2003, 278:46321-46328.
33. Velan B., Cohen S., Grosfeld H., Leitner M., Shafferman A. Bovine interferon alpha genes. Structure and expression. J. Biol. Chem. 1985, 260:5498-5504.
34. Wetzel R. Assignment of the disulphide bonds of leukocyte interferon. Nature 1981, 289:606-607.
35. Wonderling R., Powell T., Baldwin S., Morales T., Snyder S., Keiser K., Hunter S., Best E., McDermott M.J., Milhausen M. Cloning, expression, purification, and biological activity of five feline type I interferons. Vet. Immunol. Immunopathol. 2002, 89:13-27.
36. Yang L.M., Xue Q.H., Sun L., Zhu Y.P., Liu W.J. Cloning and characterization of a novel feline IFN-omega. J. Interferon Cytokine Res. 2007, 27:119-127.
37. Yao Q., Fischer K.P., Arnesen K., Tyrrell D.L., Gutfreund K.S. Molecular cloning, expression and characterization of Pekin duck interferon-lambda. Gene 2014, 548:29-38.
38. Zhao X., Cheng G., Yan W., Liu M., He Y., Zheng Z. Characterization and virus-induced expression profiles of the porcine interferon-omega multigene family. J. Interferon Cytokine Res. 2009, 29:687-693.